![W. Hertz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Hertz
Vorstandsvorsitzender bei
GRI BIO, INC.
Vermögen: 14 $ am 30.06.2026
Profil
Dr. W.
M.
Hertz is a President, Chief Executive Officer & Director at GRI Bio, Inc., a President, Chief Executive Officer & Director at GRI Bio Operations, Inc. and a Chairman at Multimeric Biotherapeutics, Inc. He is on the Board of Directors at GRI Bio, Inc. and GRI Bio Operations, Inc. Dr. Hertz was previously employed as a Chief Executive Officer & Director by Vallon Pharmaceuticals, Inc., a Chairman by Evozym Biologics, Inc., and a Chief Executive Officer by Pharmexa, Inc. (New York).
He also served on the board at Gemvax AS.
He received his undergraduate degree from Bowdoin College and a doctorate degree from CU Anschutz Medical Campus.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.01.2026 | 8 ( 0% ) | 14 $ | 30.06.2026 |
Aktive Positionen von W. Hertz
| Unternehmen | Position | Beginn |
|---|---|---|
| GRI BIO, INC. | Vorstandsvorsitzender | 01.04.2023 |
Multimeric Biotherapeutics, Inc.
 Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Gründer | 01.01.1998 |
GRI Bio Operations, Inc.
 GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von W. Hertz
| Unternehmen | Position | Ende |
|---|---|---|
Evozym Biologics, Inc.
 Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Vorsitzender | 01.01.2018 |
Gemvax AS
 Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Direktor/Vorstandsmitglied | 01.01.2009 |
Pharmexa, Inc. (New York) | Vorstandsvorsitzender | 01.08.2008 |
| GRI BIOPAR | Vorstandsvorsitzender | - |
Ausbildung von W. Hertz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Evozym Biologics, Inc.
Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Commercial Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Pharmexa, Inc. (New York) | |
Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Health Technology |
GRI Bio Operations, Inc.
GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Health Technology |
CU Anschutz Medical Campus
 CU Anschutz Medical Campus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
Wählen Sie MarketScreener 
